September 27, 2021

Volume XI, Number 270

Advertisement

September 27, 2021

Subscribe to Latest Legal News and Analysis

How Safe is CBD?

The European Court of Justice had a progressive reading last November of the two international reference texts for CBD: the 1971 United Nations Convention on psychotropic substances and the United Nations Convention of 1961 on narcotics. It was concluded that CBD does not behave, in principle as a psychotropic drug and in the current state of scientific knowledge, cannot be qualified as a ‘narcotic.’ As a result, Articles 34 and 36 of the TFEU that guarantee free movement are, in principle, applicable.

The move was hailed by the food industry as a step forward in favor of ‘trendy’ products containing CBD. In the rest of the world, the signals seem less positive. Thailand, for example, has set new limits and the US FDA continues to sanction over-the-counter products.

© 2021 Keller and Heckman LLPNational Law Review, Volume XI, Number 85
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement

About this Author

Keller and Heckman offers global food and drug services to its clients. Our comprehensive and extensive food and drug practice is one of the largest in the world. We promote, protect, and defend products made by the spectrum of industries regulated by the U.S. Food and Drug Administration (FDA), the European Commission and Member States authorities in the European Union (EU) and similar authorities throughout the world. The products we help get to market include foods, pharmaceuticals, medical devices, veterinary products, dietary supplements, and cosmetics. In addition...

202-434-4100
Advertisement
Advertisement
Advertisement